MedX Health Corp. Stock Toronto S.E.
Equities
MDX
CA5850901037
Advanced Medical Equipment & Technology
Sales 2022 | 511K 373K | Sales 2023 | 456K 333K | Capitalization | 15.72M 11.48M |
---|---|---|---|---|---|
Net income 2022 | -5M -3.65M | Net income 2023 | -4M -2.92M | EV / Sales 2022 | 22.1 x |
Net Debt 2022 | 4.86M 3.55M | Net Debt 2023 | 5.71M 4.17M | EV / Sales 2023 | 47 x |
P/E ratio 2022 |
-1.25
x | P/E ratio 2023 |
-2.58
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.77% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Lockyer
CEO | Chief Executive Officer | - | 23-04-24 |
Director of Finance/CFO | - | 22-04-28 | |
Bill Mitoulas
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hennigar
BRD | Director/Board Member | 84 | 01-11-18 |
Kenneth McKay
CHM | Chairman | - | 01-11-18 |
Stephen Lockyer
CEO | Chief Executive Officer | - | 23-04-24 |
1st Jan change | Capi. | |
---|---|---|
+4.57% | 212B | |
+8.61% | 186B | |
+26.34% | 151B | |
+33.90% | 114B | |
+2.17% | 65.57B | |
+14.50% | 52.61B | |
-3.30% | 46.8B | |
-3.98% | 38.95B | |
+6.66% | 37.64B |